Comparison of the latest commercial short and long oligonucleotide microarray technologies
2006

Comparison of Microarray Technologies for Gene Expression Analysis

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): de Reyniès Aurélien, Geromin Daniela, Cayuela Jean-Michel, Petel Fabien, Dessen Philippe, Sigaux François, Rickman David S

Primary Institution: Ligue Nationale Contre Le Cancer, Paris, France

Hypothesis

How do different commercial microarray platforms compare in terms of precision and accuracy of gene expression measurements?

Conclusion

One-color microarrays showed higher reproducibility than two-color arrays, with Affymetrix data being more concordant with QRT-PCR results.

Supporting Evidence

  • One-color platforms yielded lower variation measures compared to two-color platforms.
  • Affymetrix data had a higher level of concordance with QRT-PCR data.
  • Agilent contributed the lowest number of discordant expression values.

Takeaway

This study looked at different ways to measure gene activity using special chips, finding that some methods work better than others.

Methodology

The study compared expression measurements from three commercial microarray platforms using RNA from three human cell lines.

Potential Biases

Some studies have conflicting conclusions or biases due to competing interests.

Limitations

The study did not validate findings with a non-microarray-based approach for all comparisons.

Participant Demographics

Human cell lines: Jurkat (T cell acute lymphoblastic leukemia), MCF7 (breast cancer), and BattP12 (mesothelioma).

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2164-7-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication